Breadcrumb

RESP  |  Translational Research in Respiratory Diseases Program

RESP Program News

We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.

New study shows associations between air pollution and respiratory health in Canada

RI-MUHC researchers demonstrate that exposure to relatively low levels of air pollution in Canada is associated...

Five RI-MUHC researchers receive new funding from MI4

Cutting-edge projects in infection and immunity supported in Round 4 of MI4’s Seed Fund Grant program

TB and COVID-19, a joint battle?

On World TB Day 2022, we are looking at how researchers from the McGill International TB Centre at the RI-MUHC are working to raise awareness and to put an end to TB.

BCG vaccine provides protection against influenza virus but not SARS-CoV-2

A new study led by RI-MUHC researchers reveals that the 100-year-old tuberculosis vaccine known as..

Beyond basic research: Coming to grips with a rare disease experience

To honour Rare Disease Day on February 28, an RI-MUHC research trainee shares the perspective he gained as a patient

RI-MUHC team uncovers new mechanism of inflammation in muscular dystrophy

A new study reveals how signals sent from damaged muscles to the bone marrow can induce long-lasting...

Fall 2021 CIHR competition results

RI-MUHC teams received $9.5 million in project funding

Three renewed Canada Research Chairs for RI-MUHC researchers

Ahmad Haidar, Dennis Jensen and Ian Watson are part of the McGill University cohort of 17 new and renewed Canada Research Chairs

Promising COVID-19 therapeutic drug to start phase 3 clinical trial in the United States

Recruitment of first U.S.-based patients in dapsone trial has started

Research on dysanapsis recognized by McGill Medstar Award for Trainees

Congratulations to RI-MUHC trainee Motahareh Vameghestahbanati!

Explore news and events at the RI-MUHC